Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 512

1.

Strength of Neisseria meningitidis binding to endothelial cells requires highly-ordered CD147/β2-adrenoceptor clusters assembled by alpha-actinin-4.

Maïssa N, Covarelli V, Janel S, Durel B, Simpson N, Bernard SC, Pardo-Lopez L, Bouzinba-Ségard H, Faure C, Scott MGH, Coureuil M, Morand PC, Lafont F, Nassif X, Marullo S, Bourdoulous S.

Nat Commun. 2017 Jun 1;8:15764. doi: 10.1038/ncomms15764.

2.

Clinical and microbiological features associated with group B Streptococcus bone and joint infections, France 2004-2014.

Kernéis S, Plainvert C, Barnier JP, Tazi A, Dmytruk N, Gislain B, Loubinoux J, El Sayed F, Cattoir V, Desplaces N, Vernet V, Morand P, Poyart C.

Eur J Clin Microbiol Infect Dis. 2017 Apr 26. doi: 10.1007/s10096-017-2983-y. [Epub ahead of print]

PMID:
28447173
3.

Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000-2016.

Fourcade G, Germi R, Guerber F, Lupo J, Baccard M, Seigneurin A, Semenova T, Morand P, Epaulard O.

PLoS One. 2017 Apr 17;12(4):e0175574. doi: 10.1371/journal.pone.0175574. eCollection 2017.

4.

Guidelines on the management of infectious encephalitis in adults.

Stahl JP, Azouvi P, Bruneel F, De Broucker T, Duval X, Fantin B, Girard N, Herrmann JL, Honnorat J, Lecuit M, Mailles A, Martinez-Almoyna L, Morand P, Piroth L, Tattevin P; reviewing group.

Med Mal Infect. 2017 May;47(3):179-194. doi: 10.1016/j.medmal.2017.01.005. Epub 2017 Apr 12. No abstract available.

PMID:
28412044
5.

Epidemiology of infectious encephalitis causes in 2016.

Boucher A, Herrmann JL, Morand P, Buzelé R, Crabol Y, Stahl JP, Mailles A.

Med Mal Infect. 2017 May;47(3):221-235. doi: 10.1016/j.medmal.2017.02.003. Epub 2017 Mar 22. Review.

PMID:
28341533
6.

Infectious encephalitis: Management without etiological diagnosis 48hours after onset.

Fillatre P, Crabol Y, Morand P, Piroth L, Honnorat J, Stahl JP, Lecuit M.

Med Mal Infect. 2017 May;47(3):236-251. doi: 10.1016/j.medmal.2017.02.004. Epub 2017 Mar 15. Review.

PMID:
28314470
7.

Real-time imaging of sodium glucose transporter (SGLT1) trafficking and activity in single cells.

Ghezzi C, Calmettes G, Morand P, Ribalet B, John S.

Physiol Rep. 2017 Feb;5(3). pii: e13062. doi: 10.14814/phy2.13062.

8.

In Vitro Activity of Ceftolozane-Tazobactam against Multidrug-Resistant Nonfermenting Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis.

Grohs P, Taieb G, Morand P, Kaibi I, Podglajen I, Lavollay M, Mainardi JL, Compain F.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02688-16. doi: 10.1128/AAC.02688-16. Print 2017 Apr.

PMID:
28096165
9.

Fatal autochthonous fulminant hepatitis E early after allogeneic stem cell transplantation.

Carré M, Thiebaut-Bertrand A, Larrat S, Leroy V, Pouzol P, Sturm N, Lhomme S, Cahn JY, Garban F, Morand P.

Bone Marrow Transplant. 2017 Apr;52(4):643-645. doi: 10.1038/bmt.2016.337. Epub 2017 Jan 9. No abstract available.

PMID:
28067868
10.

TLR-2 Recognizes Propionibacterium acnes CAMP Factor 1 from Highly Inflammatory Strains.

Lheure C, Grange PA, Ollagnier G, Morand P, Désiré N, Sayon S, Corvec S, Raingeaud J, Marcelin AG, Calvez V, Khammari A, Batteux F, Dréno B, Dupin N.

PLoS One. 2016 Nov 30;11(11):e0167237. doi: 10.1371/journal.pone.0167237. eCollection 2016.

11.

Herpes simplex type 2 encephalitis and methotrexate medication: a fortuitous or causative association in a patient with spondyloarthritis?

Lupo J, Dos Santos O, Germi R, Baccard-Longère M, Stahl JP, Epaulard O, Morand P.

Antivir Ther. 2016 Nov 23. doi: 10.3851/IMP3110. [Epub ahead of print]

PMID:
27879484
12.

Dynamics of Epstein-Barr viral load after hematopoietic stem cell transplantation and effect of preemptive rituximab therapy.

Raberahona M, Wackenheim C, Germi R, Carré M, Bulabois CE, Thiébaut A, Lupo J, Semenova T, Cahn JY, Morand P, Epaulard O.

Transpl Infect Dis. 2016 Dec;18(6):889-895. doi: 10.1111/tid.12618. Epub 2016 Nov 24.

PMID:
27696681
13.

First next-generation sequencing full-genome characterization of a hepatitis C virus genotype 7 divergent subtype.

Salmona M, Caporossi A, Simmonds P, Thélu MA, Fusillier K, Mercier-Delarue S, De Castro N, LeGoff J, Chaix ML, François O, Simon F, Morand P, Larrat S, Maylin S.

Clin Microbiol Infect. 2016 Nov;22(11):947.e1-947.e8. doi: 10.1016/j.cmi.2016.07.032. Epub 2016 Aug 8.

PMID:
27515394
14.

Cluster-dependent colistin hetero-resistance in Enterobacter cloacae complex.

Guérin F, Isnard C, Sinel C, Morand P, Dhalluin A, Cattoir V, Giard JC.

J Antimicrob Chemother. 2016 Nov;71(11):3058-3061. Epub 2016 Jul 11.

PMID:
27494907
15.

Guillain-Barré syndrome and cytomegalovirus infection during pregnancy.

Lupo J, Germi R, Jean D, Baccard-Longère M, Casez O, Besson G, Rougé A, Boutonnat J, Schwebel C, Hoffmann P, Morand P.

J Clin Virol. 2016 Jun;79:74-76. doi: 10.1016/j.jcv.2016.04.010. Epub 2016 Apr 14.

PMID:
27105316
16.

Multicenter Evaluation of Whole-Blood Epstein-Barr Viral Load Standardization Using the WHO International Standard.

Semenova T, Lupo J, Alain S, Perrin-Confort G, Grossi L, Dimier J, Epaulard O, Morand P, Germi R; French EBV Study Group.

J Clin Microbiol. 2016 Jul;54(7):1746-50. doi: 10.1128/JCM.03336-15. Epub 2016 Apr 13.

17.

Hepatitis C virus whole genome sequencing: Current methods/issues and future challenges.

Trémeaux P, Caporossi A, Thélu MA, Blum M, Leroy V, Morand P, Larrat S.

Crit Rev Clin Lab Sci. 2016 Oct;53(5):341-51. doi: 10.3109/10408363.2016.1163663. Epub 2016 Apr 12.

PMID:
27068766
18.

Methylation of Epstein-Barr virus Rta promoter in EBV primary infection, reactivation and lymphoproliferation.

Germi R, Guigue N, Lupo J, Semenova T, Grossi L, Vermeulen O, Epaulard O, de Fraipont F, Morand P.

J Med Virol. 2016 Oct;88(10):1814-20. doi: 10.1002/jmv.24524. Epub 2016 Mar 28.

PMID:
26990870
19.

Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains.

Trémeaux P, Caporossi A, Ramière C, Santoni E, Tarbouriech N, Thélu MA, Fusillier K, Geneletti L, François O, Leroy V, Burmeister WP, André P, Morand P, Larrat S.

Clin Microbiol Infect. 2016 May;22(5):460.e1-460.e10. doi: 10.1016/j.cmi.2016.01.015. Epub 2016 Jan 28.

20.

Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice.

Potard V, Reynes J, Ferry T, Aubin C, Finkielsztejn L, Yazdanpanah Y, Costagliola D; FHDH ANRS CO4.

PLoS One. 2015 Dec 29;10(12):e0144746. doi: 10.1371/journal.pone.0144746. eCollection 2015.

Supplemental Content

Loading ...
Support Center